{
    "2018-08-13": [
        [
            {
                "time": "",
                "original_text": "医疗保健：挖掘估值切换带来的优质股价值投资机会 荐1股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "估值切换",
                        "优质股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "14天倒计时，400亿增量资金将驰援A股",
                "features": {
                    "keywords": [
                        "增量资金",
                        "A股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "66亿主力资金近三日杀入股权激励概念股",
                "features": {
                    "keywords": [
                        "主力资金",
                        "股权激励",
                        "概念股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：中国制药业绝对龙头 业绩持续稳增",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "制药业",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "抗癌药医保品种加速放量！阿帕替尼大增77%",
                "features": {
                    "keywords": [
                        "抗癌药",
                        "医保",
                        "阿帕替尼"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "午间重磅公告：一公司产品拟纳入优先审评程序",
                "features": {
                    "keywords": [
                        "公告",
                        "优先审评",
                        "产品"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：业绩持续稳增 增持评级",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "业绩增长",
                        "增持评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]一致性评价专题报告(医药生物行业)：进口替代成政策基调 注射剂争相布局硝烟再起",
                "features": {
                    "keywords": [
                        "强于大市",
                        "医药生物",
                        "进口替代",
                        "注射剂"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "以上养老保险将向全国推广 哪些养老概念股或利好",
                "features": {
                    "keywords": [
                        "养老保险",
                        "养老概念股",
                        "推广"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "保险"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上证50指数跌近2% 成分股普遍飘绿",
                "features": {
                    "keywords": [
                        "上证50",
                        "指数下跌",
                        "成分股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "大盘反弹的时间窗口已经达到",
                "features": {
                    "keywords": [
                        "大盘反弹",
                        "时间窗口"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药:收入增速符合预期,股权激励费用影响业绩,创新品种逐步推进",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "收入增速",
                        "股权激励",
                        "创新品种"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}